The U.S. Food and Drug Administration (FDA) has sent a warning letter to Curaleaf, a company that markets cannabidiol-based products using “unsubstantiated” health claims. Continue Reading →
Tag Archives: Dr. Ned Sharpless
FDA Taking Steps To Lower Generic Drug Prices From Harlem To Hollywood
When he served as commissioner of the Food and Drug Administration (FDA), Dr. Scott Gottlieb pressed for lower prescription drug prices by speeding development of generic alternatives. Continue Reading →
